Please login to the form below

Not currently logged in
Email:
Password:

The Netherlands

This page shows the latest The Netherlands news and features for those working in and with pharma, biotech and healthcare.

Vertex to Theresa May: Orkambi verdict ‘threatens bio investment’

Vertex to Theresa May: Orkambi verdict ‘threatens bio investment’

price that is reflective of the exceptionally high prevalence of CF in the UK”. ... only medicines that treat the underlying cause of CF”, when patients in other European countries including Ireland, Sweden, Germany, Austria, Italy, Denmark and the

Latest news

  • UniQure’s starts pivotal haemophilia B gene therapy trial UniQure’s starts pivotal haemophilia B gene therapy trial

    AMT-061 has an eight- to nine-fold increase in factor IX activity, according to the Netherlands-based biotech. ... Demand for the 1m therapy proved scant, however, and it was taken off the market last year.

  • Daily Brief Daily Brief

    Daily Brief. A rapid round-up of the top pharma, biotech and healthcare news. ... Netherlands, and says an algorithm they have developed could set prices for innovative cancer treatments with ‘a maximum level of transparency’.

  • EMA’s Amsterdam home will not be ready in time EMA’s Amsterdam home will not be ready in time

    The European Medicines Agency’s relocation from the UK to the Netherlands is being complicated by a need to move into temporary accommodation in the first instance. ... although] we will at least be able to host our core scientific meetings in the

  • Roche and GE Healthcare plan 'industry first' digital platform Roche and GE Healthcare plan 'industry first' digital platform

    degree. We believe this alliance will help accelerate the delivery of data-driven precision health for customers, patients and the healthcare industry.”. ... the US, UK, Germany, Spain, Sweden, Switzerland and the Netherlands.

  • Novartis’ Cosentyx takes on Humira and biosimilar in phase III showdown Novartis’ Cosentyx takes on Humira and biosimilar in phase III showdown

    The head-to-head trials will evaluate findings in patients with PsA and AS. ... Amsterdam Rheumatology and Clinical Immunology Centre and the Zuyderland Medical Centre in the Netherlands.

More from news
Approximately 3 fully matching, plus 183 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 25 partially matching documents found.

Latest appointments

  • Swiss biotech Inositec appoints new chief medical officer Swiss biotech Inositec appoints new chief medical officer

    Swiss biotech Inositec appoints new chief medical officer. Dr Frits van Alphen joins the group from Roche. ... Novartis as well as heading their clinical operations team in the Netherlands.

  • Bayer appoints Wolfgang Nickl as chief financial officer Bayer appoints Wolfgang Nickl as chief financial officer

    Bayer has appointed a new chief financial officer in the form of Wolfgang Nickl, who will take over from Johannes Dietsch on June 1, 2018. ... Nickl has already been the CFO of several companies in the United States and the Netherlands and is currently

  • Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel

    Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel. They will join the board of directors. ... Verwiel has also served at Merck &Co, where he was vice president and was general manager at Merck Sharpe Dohme’s operations in the

  • Hywel Day joins Napp Pharmaceuticals Hywel Day joins Napp Pharmaceuticals

    At that company he served in a general manager role, based in The Netherlands, where he led the business through a substantial transformation, which involved a significant cultural shift and a ... on our promises to the NHS, patients, our business

  • uniQure appoints chief executive officer uniQure appoints chief executive officer

    uniQure appoints chief executive officer. Matthew Kapusta takes up the lead role in a permanent capacity. ... Based in the Netherlands and the US, uniQure has appointed Matthew Kapusta as its chief executive officer.

More from appointments
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 13 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

Transforming healthcare through effective collaboration. Making work to feel proud of. www.dovetailstrategies.com...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics